These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6413231

  • 1. Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.
    Tissari AH, Rossetti ZL, Meloni M, Frau MI, Gessa GL.
    Eur J Pharmacol; 1983 Aug 05; 91(4):463-8. PubMed ID: 6413231
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of dopamine synthesis in striatal synaptosomes by lisuride: stereospecific reversal by (-)-sulpiride.
    Tissari AH, Atzori L, Galdieri MT.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Feb 05; 322(1):89-91. PubMed ID: 6843693
    [Abstract] [Full Text] [Related]

  • 3. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
    Svensson K, Ekman A, Piercey MF, Hoffmann WE, Lum JT, Carlsson A.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep 05; 344(3):263-74. PubMed ID: 1683686
    [Abstract] [Full Text] [Related]

  • 4. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D, Salah RS, Galloway MP.
    Synapse; 1991 Jul 05; 8(3):169-76. PubMed ID: 1948667
    [Abstract] [Full Text] [Related]

  • 5. Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
    Barton AC, Moore KE, Demarest KT.
    J Neural Transm; 1987 Jul 05; 68(1-2):25-39. PubMed ID: 2879883
    [Abstract] [Full Text] [Related]

  • 6. Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism.
    Kehr W.
    Eur J Pharmacol; 1984 Jan 13; 97(1-2):111-9. PubMed ID: 6421606
    [Abstract] [Full Text] [Related]

  • 7. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Forloni G, Bidzinski A, Fusi R, Ladinsky H, Consolo S.
    Life Sci; 1987 Oct 05; 41(14):1717-23. PubMed ID: 2958667
    [Abstract] [Full Text] [Related]

  • 8. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A, Fadda F, Melis MR, Marcou M, Porceddu ML, Gessa GL.
    Eur J Pharmacol; 1982 Nov 05; 85(1):23-7. PubMed ID: 6818043
    [Abstract] [Full Text] [Related]

  • 9. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb 05; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 10. Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics.
    Horowski R.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar 05; 306(2):147-51. PubMed ID: 36572
    [Abstract] [Full Text] [Related]

  • 11. [Suppressive effects of lisuride on the synthesis, release and metabolism of dopamine in rat brain].
    Azuma H, Iwai K, Sato K, Kikuta M, Liu HJ, Oshino N.
    Nihon Yakurigaku Zasshi; 1982 Nov 05; 80(5):325-39. PubMed ID: 6131854
    [Abstract] [Full Text] [Related]

  • 12. Failure of subchronic lisuride to modify A10 dopamine autoreceptors' sensitivity.
    Mereu G, Hu XT, Wang RY, Westfall TC, Gessa GL.
    Brain Res; 1987 Apr 07; 408(1-2):210-4. PubMed ID: 2885067
    [Abstract] [Full Text] [Related]

  • 13. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.
    Wolf ME, Galloway MP, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar 07; 236(3):699-707. PubMed ID: 2869140
    [Abstract] [Full Text] [Related]

  • 14. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP, Wolf ME, Roth RH.
    J Pharmacol Exp Ther; 1986 Mar 07; 236(3):689-98. PubMed ID: 3081705
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the potencies of various dopamine receptor agonists in models for pre- and postsynaptic receptor activity.
    Feenstra MG, Sumners C, Goedemoed JH, de Vries JB, Rollema H, Horn AS.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep 07; 324(2):108-15. PubMed ID: 6646238
    [Abstract] [Full Text] [Related]

  • 16. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
    Yoshida ST, Baella SA, Stuebner NM, Crawford CA, McDougall SA.
    Brain Res; 2006 Feb 16; 1073-1074():269-75. PubMed ID: 16427034
    [Abstract] [Full Text] [Related]

  • 17. [Effects of an ergot derivative, lisuride, on the central dopaminergic system -- studies of behavioral pharmacology].
    Hara K, Ikoma Y, Oshino N.
    Nihon Yakurigaku Zasshi; 1982 Jul 16; 80(1):1-13. PubMed ID: 7173731
    [Abstract] [Full Text] [Related]

  • 18. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P, Olianas MC, Gessa GL.
    Mol Pharmacol; 1985 Aug 16; 28(2):138-45. PubMed ID: 2410769
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.